Old Web
English
Sign In
Acemap
>
authorDetail
>
Robert C. Flanigan
Robert C. Flanigan
Loyola University Chicago
Medicine
Fluorouracil
Cancer
Pathology
Renal cell carcinoma
3
Papers
89
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Diversity of the midstream urine microbiome in adults with chronic kidney disease
2018
International Urology and Nephrology
Holly Kramer
Gina Kuffel
Krystal Thomas-White
Alan J. Wolfe
Kavitha Vellanki
David J. Leehey
Vinod Bansal
Linda Brubaker
Robert C. Flanigan
Julia Koval
Anuradha Wadhwa
Michael J. Zilliox
Show All
Source
Cite
Save
Citations (24)
Infusional interleukin‐2 and 5‐fluorouracil with subcutaneous interferon‐α for the treatment of patients with advanced renal cell carcinoma
2000
Cancer
Laurence Elias
Danika Lew
Robert A. Figlin
Robert C. Flanigan
Mark E. Thompson
Pierre L. Triozzi
Robert J. Belt
David P. Wood
Saul E. Rivkin
E. David Crawford
Show All
Source
Cite
Save
Citations (24)
Evaluation of low dose continuous infusion 5‐fluorouracil in patients with advanced and recurrent renal cell carcinoma. A Southwest Oncology Group study
1994
Cancer
Julie A. Kish
Michael Wolf
E. David Crawford
Joseph T. Leimert
Anton Bueschen
John R. Neefe
Robert C. Flanigan
Show All
Source
Cite
Save
Citations (41)
1